Finorify

ALNY

Alnylam Pharmaceuticals

$283.12+1.43%

Price

ALNY daily closing price
Market cap
$37.8 billion
P/E (TTM)
71.14
EV/EBITDA
46.09
Volume
1.1M
Sector
Healthcare

Alnylam Pharmaceuticals (ALNY) last closed at $283.12, on a daily price path from October 21, 2025 to October 21, 2026. Overview is that price path. Performance is the change in the close over the periods Finorify shows on the stock screen. Financials, cash flow, and margins come from reported quarters. Valuation lists the latest ratios. This snapshot is the Finorify stock screen for ALNY, covered for search and blurred for visitors.

Performance

  • 1D-2.43%
  • 5D+0.28%
  • 1M-10.55%
  • 3M-16.24%
  • 6M-27.52%
  • 1Y-54.18%
  • 5Y+10.40%

Financials

ALNY revenueQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q2 '26

Over the latest four reported periods ending June 30, 2026, Alnylam Pharmaceuticals reported revenue of $4.41 billion.

The prior window totaled $2.35 billion, so the latest window is higher than that stretch.

Operating cash flow in the latest window was $1.04 billion.

Free cash flow in the latest window was $933.4 million.

These amounts are taken from Alnylam Pharmaceuticals's SEC filings and are a snapshot as of August 22, 2026. They are not a live price, and they are not a recommendation to buy or sell. Finorify uses the same filings to draw the charts inside the app.

A few ratios from those statements: Profitability: ROE 12.1% (43 of 100). Cash generation: FCF margin 21.2% (42 of 100). Net margin: 12.7% (32 of 100). Liquidity: Current 3.05× (100 of 100).

Cash Flow

ALNY free cash flowQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q2 '26

Margins

ALNY operating margin

Valuation

P/E (TTM)
71.14
P/S (TTM)
8.58
EV/EBITDA
46.09

Insights

Finorify has not written notes for ALNY in this snapshot.

Read the live analysis in Finorify

Charts, news, and the written notes are in the app. You can open five distinct stocks free. After that, the stock screen is a Finorify Pro feature.

Open ALNY in Finorify